Atlas Trials

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Clinical trial NCT00951574 · COMPLETED

Trial details

NCT number
NCT00951574
Sponsor
Italfarmaco
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced CancerMetastatic Cancer
Start date
2003-10-01
Primary completion
2007-05-01
Enrollment
1166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.